Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Evolutionary trajectories of new duplicated and putative de novo genes

  • Montañés, José Carlos
  • Huertas, Marta
  • Messeguer, Xavier
  • Albà Soler, Mar
The formation of new genes during evolution is an important motor of functional innovation, but the rate at which new genes originate and the likelihood that they persist over longer evolutionary periods are still poorly understood questions. Two important mechanisms by which new genes arise are gene duplication and de novo formation from a previously noncoding sequence. Does the mechanism of formation influence the evolutionary trajectories of the genes? Proteins arisen by gene duplication retain the sequence and structural properties of the parental protein, and thus they may be relatively stable. Instead, de novo originated proteins are often species specific and thought to be more evolutionary labile. Despite these differences, here we show that both types of genes share a number of similarities, including low sequence constraints in their initial evolutionary phases, high turnover rates at the species level, and comparable persistence rates in deeper branchers, in both yeast and flies. In addition, we show that putative de novo proteins have an excess of substitutions between charged amino acids compared with the neutral expectation, which is reflected in the rapid loss of their initial highly basic character. The study supports high evolutionary dynamics of different kinds of new genes at the species level, in sharp contrast with the stability observed at later stages., We acknowledge funding from Ministerio de Ciencia e Innovación Agencia Estatal de Investigación grant PGC2018-094091-B-I00 (cofunded by Fondo Europeo de Desarrollo Regional), as well as grants PID2021-122726NB-I00 and PID2021-122830OB-C43 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF: A way of making Europe”, by the “European Union”. We also acknowledge funding from Generalitat de Catalunya, grant 2021SGR00042. The work was also funded by the European Union (ERC, NovoGenePop, project number 101052538). Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

High polymorphism levels of de novo ORFs in a Yoruba human population

  • Vara, Covadonga
  • Montañés, José Carlos
  • Albà Soler, Mar
During evolution, new open reading frames (ORFs) with the potential to give rise to novel proteins continuously emerge. A recent compilation of noncanonical ORFs with translation signatures in humans has identified thousands of cases with a putative de novo origin. However, it is not known which is their distribution in the population. Are they universally translated? Here, we use ribosome profiling data from 65 lymphoblastoid cell lines from individuals of Yoruba origin to investigate this question. We identify 2,587 de novo ORFs translated in at least one of the cell lines. In line with their de novo origin, the encoded proteins tend to be smaller than 100 amino acids and encode positively charged proteins. We observe that the de novo ORFs are more polymorphic in the population than the set of canonical proteins, with a substantial fraction of them being translated in only some of the cell lines. Remarkably, this difference remains significant after controlling for differences in the translation levels. These results suggest that variations in the level translation of de novo ORFs could be a relevant source of intraspecies phenotypic diversity in humans., The work was supported by grant PID2021-122726NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by "ERDF: A way of making Europe," by the "European Union." It also received support from grant 2021SGR00042 by Generalitat de Catalunya. It was also funded by the European Research Council Advanced Grant NovoGenePop 101052538. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort

  • Camarena, Marta E.
  • Theunissen, Patrick
  • Ruiz, Marta
  • Ruiz Orera, Jorge, 1988-
  • Calvo Serra, Beatriz
  • Castelo Valdueza, Robert
  • Castro Alejos, Carla
  • Sarobe, Pablo
  • Fortes, Puri
  • Perera Bel, Júlia
  • Albà Soler, Mar
The expression of tumor-specific antigens during cancer progression can trigger an immune response against the tumor. Here, we investigate if microproteins encoded by noncanonical open reading frames (ncORFs) are a relevant source of tumor-specific antigens. We analyze RNA sequencing data from 117 hepatocellular carcinoma (HCC) tumors and matched healthy tissue together with ribosome profiling and immunopeptidomics data. Combining human leukocyte antigen-epitope binding predictions and experimental validation experiments, we conclude that around 40% of the tumor-specific antigens in HCC are likely to be derived from ncORFs, including two peptides that can trigger an immune response in humanized mice. We identify a subset of 33 tumor-specific long noncoding RNAs expressing novel cancer antigens shared by more than 10% of the HCC samples analyzed, which, when combined, cover a large proportion of the patients. The results of the study open avenues for extending the range of anticancer vaccines., This work was supported by the following grants and agencies: research projects PID2019-105595GB, PID2021-122726NB-I00, and PID2021-128791OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF: A way of making Europe” by the “European Union”; PI19/00004, PI20/00260, and PI22/00171, funded by Instituto de Salud Carlos III (ISCIII) and cofunded by the European Union and FEDER; 0011-1383-2019-000006 and 0011-1411-2021-000070, funded by Gobierno de Navarra; RTI2018-101759-B-I00 and the Instituto de Salud Carlos III, which finances Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREhd) and Red Española de Terapias Avanzadas TERAV ISCIII [RICORS: (RD21/0017), financed by the EU (NextGenerationEU, Plan de Recuperación Transformación y Resiliencia)]; AECC IDEAS20169FORT by Scientific Foundation of the Spanish Association Against Cancer; 2021SGR00042 by Generalitat de Catalunya; Ayudas Fundación BBVA a Proyectos de Investigación Científica en Biomedicina 2021; and European Reseach Council Advanced Grant NovoGenePop 101052538. Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

High polymorphism levels of de novo ORFs in a Yoruba human population

  • Vara, Covadonga
  • Montañés, José Carlos
  • Albà Soler, Mar
During evolution, new open reading frames (ORFs) with the potential to give rise to novel proteins continuously emerge. A recent compilation of noncanonical ORFs with translation signatures in humans has identified thousands of cases with a putative de novo origin. However, it is not known which is their distribution in the population. Are they universally translated? Here, we use ribosome profiling data from 65 lymphoblastoid cell lines from individuals of Yoruba origin to investigate this question. We identify 2,587 de novo ORFs translated in at least one of the cell lines. In line with their de novo origin, the encoded proteins tend to be smaller than 100 amino acids and encode positively charged proteins. We observe that the de novo ORFs are more polymorphic in the population than the set of canonical proteins, with a substantial fraction of them being translated in only some of the cell lines. Remarkably, this difference remains significant after controlling for differences in the translation levels. These results suggest that variations in the level translation of de novo ORFs could be a relevant source of intraspecies phenotypic diversity in humans., The work was supported by grant PID2021-122726NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by "ERDF: A way of making Europe," by the "European Union." It also received support from grant 2021SGR00042 by Generalitat de Catalunya. It was also funded by the European Research Council Advanced Grant NovoGenePop 101052538. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Evolutionary trajectories of new duplicated and putative de novo genes

  • Montañés, José Carlos
  • Huertas, Marta
  • Messeguer, Xavier
  • Albà Soler, Mar
The formation of new genes during evolution is an important motor of functional innovation, but the rate at which new genes originate and the likelihood that they persist over longer evolutionary periods are still poorly understood questions. Two important mechanisms by which new genes arise are gene duplication and de novo formation from a previously noncoding sequence. Does the mechanism of formation influence the evolutionary trajectories of the genes? Proteins arisen by gene duplication retain the sequence and structural properties of the parental protein, and thus they may be relatively stable. Instead, de novo originated proteins are often species specific and thought to be more evolutionary labile. Despite these differences, here we show that both types of genes share a number of similarities, including low sequence constraints in their initial evolutionary phases, high turnover rates at the species level, and comparable persistence rates in deeper branchers, in both yeast and flies. In addition, we show that putative de novo proteins have an excess of substitutions between charged amino acids compared with the neutral expectation, which is reflected in the rapid loss of their initial highly basic character. The study supports high evolutionary dynamics of different kinds of new genes at the species level, in sharp contrast with the stability observed at later stages., We acknowledge funding from Ministerio de Ciencia e Innovación Agencia Estatal de Investigación grant PGC2018-094091-B-I00 (cofunded by Fondo Europeo de Desarrollo Regional), as well as grants PID2021-122726NB-I00 and PID2021-122830OB-C43 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF: A way of making Europe”, by the “European Union”. We also acknowledge funding from Generalitat de Catalunya, grant 2021SGR00042. The work was also funded by the European Union (ERC, NovoGenePop, project number 101052538). Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort

  • Camarena, Marta E.
  • Theunissen, Patrick
  • Ruiz, Marta
  • Ruiz Orera, Jorge, 1988-
  • Calvo Serra, Beatriz
  • Castelo Valdueza, Robert
  • Castro Alejos, Carla
  • Sarobe, Pablo
  • Fortes, Puri
  • Perera Bel, Júlia
  • Albà Soler, Mar
The expression of tumor-specific antigens during cancer progression can trigger an immune response against the tumor. Here, we investigate if microproteins encoded by noncanonical open reading frames (ncORFs) are a relevant source of tumor-specific antigens. We analyze RNA sequencing data from 117 hepatocellular carcinoma (HCC) tumors and matched healthy tissue together with ribosome profiling and immunopeptidomics data. Combining human leukocyte antigen-epitope binding predictions and experimental validation experiments, we conclude that around 40% of the tumor-specific antigens in HCC are likely to be derived from ncORFs, including two peptides that can trigger an immune response in humanized mice. We identify a subset of 33 tumor-specific long noncoding RNAs expressing novel cancer antigens shared by more than 10% of the HCC samples analyzed, which, when combined, cover a large proportion of the patients. The results of the study open avenues for extending the range of anticancer vaccines., This work was supported by the following grants and agencies: research projects PID2019-105595GB, PID2021-122726NB-I00, and PID2021-128791OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF: A way of making Europe” by the “European Union”; PI19/00004, PI20/00260, and PI22/00171, funded by Instituto de Salud Carlos III (ISCIII) and cofunded by the European Union and FEDER; 0011-1383-2019-000006 and 0011-1411-2021-000070, funded by Gobierno de Navarra; RTI2018-101759-B-I00 and the Instituto de Salud Carlos III, which finances Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREhd) and Red Española de Terapias Avanzadas TERAV ISCIII [RICORS: (RD21/0017), financed by the EU (NextGenerationEU, Plan de Recuperación Transformación y Resiliencia)]; AECC IDEAS20169FORT by Scientific Foundation of the Spanish Association Against Cancer; 2021SGR00042 by Generalitat de Catalunya; Ayudas Fundación BBVA a Proyectos de Investigación Científica en Biomedicina 2021; and European Reseach Council Advanced Grant NovoGenePop 101052538. Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them.